Indianapolis-based pharmaceuticals giant Eli Lilly has developed a canine version of Prozac:
To be marketed under the name Reconcile…the drug is chewable and flavored with a doggie-delectable zing. It is the latest in a string of recently approved canine drugs, reflecting the growing market for pet pharmaceuticals…The U. S. Food and Drug Administration approved Reconcile in February after clinical tests in dogs showed it significantly improved symptoms of separation anxiety, a problem that strikes 10 to 20 percent of canines with varying severity; dogs affected may bark, chew household items, or urinate in inappropriate locations when left alone. The drug, which will go on the market in April and will be sold along with a behavior modification program, is the first product introduced by a new division of Lilly devoted entirely to pets.
(From MIT Technology Review)